All companies, by profit
508 companies and 2245 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net profit | Quarter |
|---|---|---|---|---|---|
| 301 |
|
$73.4B | $818.76 −11.0% | −$6.9B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 LITE Lumentum |
| 302 |
|
$323B | $64.00 −30.5% | −$12.0B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 INTC Intel |
| 303 |
|
$49.5B | $128.78 −9.1% | −$30.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 MSTR Strategy |
| Not ranked below this line: we do not hold four quarters in a row, or a quarter's bottom line is withheld because the filing's copy of it cannot be trusted, so the figure is not the same quantity as the ones above it. | |||||
| – |
|
$371B | $150.41 +2.8% | $15.3B 3 of four quarters in a row 2025: Q1, Q2, Q3 | Q3 FY25 MRK Merck & Co. |
| – |
|
$667B | $276.69 +0.5% | $11.0B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 JNJ Johnson & Johnson |
| – |
|
$1.57T | $616.26 −1.3% | $9.9B 1 of four quarters in a row 2026: Q3 | Q3 FY26 META Meta Platforms |
| – |
|
$81.6B | $23.00 +3.3% | $9.1B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 CMCSA Comcast |
| – |
|
$116B | $90.71 +0.4% | $8.9B 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| – |
|
$27.8B | $95.85 −1.9% | $8.3B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 ECHO EchoStar |
| – |
|
$129B | $62.97 +2.6% | $8.2B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 BMY Bristol Myers Squibb |
| – |
|
$125B | $203.17 −2.7% | $7.5B 3 of four quarters in a row 2026: Q1 · 2025: Q3, Q4 | Q1 FY26 COF Capital One |
| – |
|
$227B | $851.96 −4.0% | $6.7B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 GEV GE Vernova |
| – |
|
$407B | $94.51 +1.8% | $4.0B 1 of four quarters in a row 2026: Q3 | Q3 FY26 KO Coca-Cola |
| – |
|
$77.1B | $87.87 +2.5% | $3.9B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 GM General Motors |
| – | SPCX outside the index SpaceX outside the index Share price: $136.14 −5.4% Q3 FY26 SPCX SpaceX | $1.79T | $136.14 −5.4% | $3.9B 2 of four quarters in a row 2026: Q2, Q3 | Q3 FY26 SPCX SpaceX |
| – |
|
$242B | $256.90 −0.5% | $3.4B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 IBM IBM |
| – |
|
$157B | $142.37 +0.7% | $2.9B 2 of four quarters in a row 2027: Q1, Q2 | Q2 FY27 TJX TJX Companies |
| – |
|
$91.4B | $421.55 −0.1% | $2.8B 2 of four quarters in a row 2026: Q2, Q3 | Q3 FY26 ELV Elevance Health |
| – |
|
$99.7B | $127.93 +1.6% | $2.7B 2 of four quarters in a row 2026: Q1 · 2025: Q4 | Q1 FY26 DUK Duke Energy |
| – |
|
$174B | $30.57 +2.1% | $2.7B 1 of four quarters in a row 2026: Q1 | Q1 FY26 PFE Pfizer |
| – |
|
$33.7B | $68.20 −0.6% | $2.6B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 CNC Centene |
| – |
|
$176B | $84.15 +2.4% | $2.4B 1 of four quarters in a row 2025: Q3 | Q3 FY25 NEE NextEra Energy |
| – |
|
$214B | $172.40 +4.1% | $2.4B 1 of four quarters in a row 2026: Q3 | Q3 FY26 GILD Gilead Sciences |
| – |
|
$96.4B | $202.04 +2.5% | $2.4B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 MRSH Marsh McLennan |
| – |
|
$80.3B | $330.67 +0.2% | $2.2B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 SHW Sherwin-Williams |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.